07.12.2017
- The US Food and Drug Administration (FDA) has given the green light to Netherlands-domiciled, US-managed generic drugmaker Mylan’s Ogivri (trastuzumab-dkst) breast cancer drug, a...
09.11.2017
- The US Food and Drug Administration has approved a new drug developed by Eli Lilly to treat a common type of breast cancer. Verzenio is recommended both for women and men with HR...
19.07.2017
- The US Food and Drug Administration (FDA) has approved Nerlynx (neratinib), made by Puma Biotechnology for the extended adjuvant treatment of early-stage, HER2-positive breast...
09.05.2017
- For as much as five months, US drugmaker Pfizer will provide its breast cancer drug palbociclib for free to the England arm of the UK’s National Health Service (NHS). The decision...
21.02.2017
- AstraZeneca has agreed to sell the commercial rights for its cancer treatment Zoladex in the US and Canada for $250 million upfront to private equity-backed TerSera Therapeutics –...
17.06.2015
- Women exposed to higher levels of the pesticide DDT while in utero face increased risk of breast cancer later in life than those exposed to lower levels, according to new research...
22.12.2014
- Swiss pharmaceutical producer group Roche said it would discontinue a late-stage study of investigational anti-amyloid medicine gantenerumab in pre-dementia Alzheimer's disease...
01.04.2010
- Exposure to certain chemicals and pollutants before a woman reaches her mid-30s could treble her risk of developing breast cancer after the menopause, Canadian scientists said on...
